Etanercept
Brand name: Enbrel Sureclick
Rank #14 of 500 drugs by total cost
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$1.12B
Total Cost
145,737
Total Claims
$1.12B
Total Cost
4,204
Prescribers
$7,682
Cost per Claim
7,027
Beneficiaries
154,601
30-Day Fills
$266K
Avg Cost/Provider
35
Avg Claims/Provider
Share of Medicare Part D Spending
0.41%
of total Medicare Part D spending
$1.12B of $275.65B
Top Prescribers by Cost
Top 10 prescribers of $1.12B total
🔎 Data Overview
Ranked #14 out of 500 drugs tracked by total cost. Etanercept represents a significant portion of Medicare drug spending.
At $7,682 per prescription, this is a high-cost medication. Expensive drugs drive Medicare spending growth and create access challenges for patients with coverage gaps.
Average cost of $266,300 per prescriber suggests this drug may be concentrated among specialists. High per-provider spending can sometimes indicate inappropriate prescribing or overly aggressive use.
Average cost of $159,318 per patient per year. Medications at this price point significantly impact patient out-of-pocket costs and Medicare spending.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Top Prescribers of Etanercept
| # | Provider | Specialty | Location | Claims | Cost |
|---|---|---|---|---|---|
| 1 | David Campbell | Rheumatology | Fort Wayne, IN | 324 | $2.7M |
| 2 | Syed Raza | Rheumatology | Memphis, TN | 365 | $2.6M |
| 3 | Ricardo Garcia Alemany | Rheumatology | Hialeah, FL | 392 | $2.5M |
| 4 | Anne Marie Holly | Physician Assistant | Rochester, NY | 295 | $2.5M |
| 5 | Luis Salayandia | Rheumatology | El Paso, TX | 310 | $2.3M |
| 6 | Ulker Tok | Rheumatology | Tucson, AZ | 292 | $2.2M |
| 7 | Mayra Acosta | Rheumatology | Miami, FL | 345 | $2.1M |
| 8 | Ari Schwartz | Rheumatology | Brockton, MA | 259 | $2.0M |
| 9 | William Chafin | Rheumatology | Athens, GA | 255 | $2.0M |
| 10 | Davi Ponte De Sa Leitao | Rheumatology | Kalamazoo, MI | 242 | $1.9M |
| 11 | Marcum Collins | Rheumatology | Knoxville, TN | 247 | $1.9M |
| 12 | Michael Elist | Rheumatology | Tarzana, CA | 249 | $1.9M |
| 13 | Fahed Hamadeh | Rheumatology | Oklahoma City, OK | 252 | $1.9M |
| 14 | Dennis Suarez | Rheumatology | Mayaguez, PR | 258 | $1.8M |
| 15 | Maria Vintimilla | Rheumatology | New Smyrna Beach, FL | 237 | $1.8M |
Top prescribers ranked by total cost for this drug in 2023.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 11 | Sitagliptin Phosphate (Januvia) | $1.54B | 1,567,668 |
| 12 | Sacubitril/Valsartan (Entresto) | $1.30B | 1,220,812 |
| 13 | Bictegrav/Emtricit/Tenofov Ala (Biktarvy) | $1.29B | 310,738 |
| 14 | Etanercept (Enbrel Sureclick) | $1.12B | 145,737 |
| 15 | Enzalutamide (Xtandi) | $985.0M | 72,710 |
| 16 | Mirabegron (Myrbetriq) | $927.5M | 1,407,073 |
| 17 | Tirzepatide (Mounjaro) | $877.9M | 680,457 |
Related Analysis
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology